HEADER HYDROLASE 03-JAN-06 2FJM TITLE THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH TITLE 2 COMPOUND 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE, NON-RECEPTOR TYPE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (RESIDUES 1-298); COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1B, PTP-1B; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN1, PTP1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS PHOSPHATASE, SECONDARY BINDING SITE, SELECTIVITY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR E.ASANTE-APPIAH,S.PATEL,C.DESPONTS,J.M.TAYLOR,C.LAU,C.DUFRESNE, AUTHOR 2 M.THERIEN,R.FRIESEN,J.W.BECKER,Y.LEBLANC,G.SCAPIN REVDAT 7 30-AUG-23 2FJM 1 REMARK REVDAT 6 20-OCT-21 2FJM 1 REMARK SEQADV LINK REVDAT 5 24-JUL-19 2FJM 1 REMARK REVDAT 4 18-OCT-17 2FJM 1 REMARK REVDAT 3 13-JUL-11 2FJM 1 VERSN REVDAT 2 16-DEC-08 2FJM 1 JRNL VERSN REVDAT 1 17-JAN-06 2FJM 0 JRNL AUTH E.ASANTE-APPIAH,S.PATEL,C.DESPONTS,J.M.TAYLOR,C.LAU, JRNL AUTH 2 C.DUFRESNE,M.THERIEN,R.FRIESEN,J.W.BECKER,Y.LEBLANC, JRNL AUTH 3 B.P.KENNEDY,G.SCAPIN JRNL TITL CONFORMATION-ASSISTED INHIBITION OF PROTEIN-TYROSINE JRNL TITL 2 PHOSPHATASE-1B ELICITS INHIBITOR SELECTIVITY OVER T-CELL JRNL TITL 3 PROTEIN-TYROSINE PHOSPHATASE. JRNL REF J.BIOL.CHEM. V. 281 8010 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16407290 JRNL DOI 10.1074/JBC.M511827200 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 56198 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3855 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.42 REMARK 3 BIN R VALUE (WORKING SET) : 0.2600 REMARK 3 BIN FREE R VALUE SET COUNT : 207 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4638 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 89 REMARK 3 SOLVENT ATOMS : 299 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 37.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.20000 REMARK 3 B22 (A**2) : -1.65000 REMARK 3 B33 (A**2) : 1.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.157 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.142 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.111 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.546 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4944 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6681 ; 1.254 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 566 ; 5.496 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 250 ;37.619 ;23.920 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 904 ;16.179 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 37 ;21.494 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 703 ; 0.084 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3765 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2202 ; 0.189 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3321 ; 0.301 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 357 ; 0.170 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 31 ; 0.191 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.151 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): 1 ; 0.040 ; 0.200 REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2976 ; 0.612 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4655 ; 1.007 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2283 ; 1.410 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2026 ; 2.159 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 497 A 615 REMARK 3 RESIDUE RANGE : A 620 A 785 REMARK 3 ORIGIN FOR THE GROUP (A): 26.0613 29.7957 1.7441 REMARK 3 T TENSOR REMARK 3 T11: -0.2674 T22: 0.0436 REMARK 3 T33: -0.1941 T12: -0.0323 REMARK 3 T13: 0.0167 T23: -0.1045 REMARK 3 L TENSOR REMARK 3 L11: 3.4482 L22: 1.9707 REMARK 3 L33: 1.8981 L12: -0.8086 REMARK 3 L13: -0.7120 L23: 0.5410 REMARK 3 S TENSOR REMARK 3 S11: 0.1481 S12: 0.5273 S13: -0.1624 REMARK 3 S21: -0.1424 S22: -0.0435 S23: -0.1457 REMARK 3 S31: -0.2104 S32: 0.0352 S33: -0.1046 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 497 B 615 REMARK 3 RESIDUE RANGE : B 620 B 785 REMARK 3 ORIGIN FOR THE GROUP (A): 8.1185 47.7955 33.0538 REMARK 3 T TENSOR REMARK 3 T11: 0.0567 T22: -0.2591 REMARK 3 T33: -0.2034 T12: -0.0309 REMARK 3 T13: 0.0959 T23: -0.0167 REMARK 3 L TENSOR REMARK 3 L11: 2.0856 L22: 3.4938 REMARK 3 L33: 1.9116 L12: -0.8657 REMARK 3 L13: -0.5801 L23: 0.7189 REMARK 3 S TENSOR REMARK 3 S11: -0.0468 S12: -0.1806 S13: 0.1574 REMARK 3 S21: 0.5087 S22: 0.1674 S23: 0.1430 REMARK 3 S31: -0.0479 S32: 0.2017 S33: -0.1205 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2FJM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-JAN-06. REMARK 100 THE DEPOSITION ID IS D_1000035954. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 61477 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 21.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.830 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06400 REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.24 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43900 REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PDB ENTRY 1PTY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, MGCL2, HEPES, PH 7.00, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 284K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.21550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.59650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.31050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.59650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.21550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.31050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 489 REMARK 465 ASP A 490 REMARK 465 TYR A 491 REMARK 465 LYS A 492 REMARK 465 ASP A 493 REMARK 465 ASP A 494 REMARK 465 ASP A 495 REMARK 465 ASP A 496 REMARK 465 LYS A 616 REMARK 465 GLY A 617 REMARK 465 SER A 618 REMARK 465 VAL A 619 REMARK 465 SER A 786 REMARK 465 VAL A 787 REMARK 465 GLN A 788 REMARK 465 ASP A 789 REMARK 465 GLN A 790 REMARK 465 TRP A 791 REMARK 465 LYS A 792 REMARK 465 GLU A 793 REMARK 465 LEU A 794 REMARK 465 SER A 795 REMARK 465 HIS A 796 REMARK 465 GLU A 797 REMARK 465 ASP A 798 REMARK 465 MET B 489 REMARK 465 ASP B 490 REMARK 465 TYR B 491 REMARK 465 LYS B 492 REMARK 465 ASP B 493 REMARK 465 ASP B 494 REMARK 465 ASP B 495 REMARK 465 ASP B 496 REMARK 465 LYS B 616 REMARK 465 GLY B 617 REMARK 465 SER B 618 REMARK 465 VAL B 619 REMARK 465 SER B 786 REMARK 465 VAL B 787 REMARK 465 GLN B 788 REMARK 465 ASP B 789 REMARK 465 GLN B 790 REMARK 465 TRP B 791 REMARK 465 LYS B 792 REMARK 465 GLU B 793 REMARK 465 LEU B 794 REMARK 465 SER B 795 REMARK 465 HIS B 796 REMARK 465 GLU B 797 REMARK 465 ASP B 798 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 497 CG CD CE NZ REMARK 470 LEU A 498 CG CD1 CD2 REMARK 470 MET A 501 CG SD CE REMARK 470 MET A 614 CG SD CE REMARK 470 LYS B 497 CG CD CE NZ REMARK 470 LEU B 498 CG CD1 CD2 REMARK 470 MET B 501 CG SD CE REMARK 470 MET B 614 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 829 O HOH B 948 1.96 REMARK 500 O HOH B 858 O HOH B 898 1.98 REMARK 500 O HOH A 809 O HOH A 929 2.12 REMARK 500 O HOH B 858 O HOH B 880 2.13 REMARK 500 NH2 ARG B 524 O HOH B 856 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 630 CD GLU A 630 OE1 0.117 REMARK 500 GLU A 630 CD GLU A 630 OE2 0.094 REMARK 500 GLU B 630 CD GLU B 630 OE1 0.101 REMARK 500 GLU B 630 CD GLU B 630 OE2 0.074 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 498 86.44 -68.10 REMARK 500 CYS A 621 142.15 -170.20 REMARK 500 CYS A 715 -133.03 -130.08 REMARK 500 ILE A 761 114.31 67.29 REMARK 500 ASP A 784 -9.68 64.02 REMARK 500 CYS B 621 139.06 -172.93 REMARK 500 CYS B 715 -131.18 -127.59 REMARK 500 ILE B 719 -43.47 -132.06 REMARK 500 ILE B 761 113.25 68.60 REMARK 500 MET B 782 57.89 -94.53 REMARK 500 ASP B 784 -43.57 63.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 800 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B 850 O REMARK 620 2 HOH B 857 O 85.2 REMARK 620 3 HOH B 873 O 111.7 77.3 REMARK 620 4 HOH B 914 O 76.6 82.6 157.2 REMARK 620 5 HOH B 945 O 146.8 67.8 81.6 81.0 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 799 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 799 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 073 A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 073 B 801 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FJN RELATED DB: PDB DBREF 2FJM A 501 798 UNP P18031 PTN1_HUMAN 1 298 DBREF 2FJM B 501 798 UNP P18031 PTN1_HUMAN 1 298 SEQADV 2FJM MET A 489 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP A 490 UNP P18031 CLONING ARTIFACT SEQADV 2FJM TYR A 491 UNP P18031 CLONING ARTIFACT SEQADV 2FJM LYS A 492 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP A 493 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP A 494 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP A 495 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP A 496 UNP P18031 CLONING ARTIFACT SEQADV 2FJM LYS A 497 UNP P18031 CLONING ARTIFACT SEQADV 2FJM LEU A 498 UNP P18031 CLONING ARTIFACT SEQADV 2FJM GLU A 499 UNP P18031 CLONING ARTIFACT SEQADV 2FJM PHE A 500 UNP P18031 CLONING ARTIFACT SEQADV 2FJM VAL A 619 UNP P18031 LEU 119 ENGINEERED MUTATION SEQADV 2FJM MET B 489 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP B 490 UNP P18031 CLONING ARTIFACT SEQADV 2FJM TYR B 491 UNP P18031 CLONING ARTIFACT SEQADV 2FJM LYS B 492 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP B 493 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP B 494 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP B 495 UNP P18031 CLONING ARTIFACT SEQADV 2FJM ASP B 496 UNP P18031 CLONING ARTIFACT SEQADV 2FJM LYS B 497 UNP P18031 CLONING ARTIFACT SEQADV 2FJM LEU B 498 UNP P18031 CLONING ARTIFACT SEQADV 2FJM GLU B 499 UNP P18031 CLONING ARTIFACT SEQADV 2FJM PHE B 500 UNP P18031 CLONING ARTIFACT SEQADV 2FJM VAL B 619 UNP P18031 LEU 119 ENGINEERED MUTATION SEQRES 1 A 310 MET ASP TYR LYS ASP ASP ASP ASP LYS LEU GLU PHE MET SEQRES 2 A 310 GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER GLY SEQRES 3 A 310 SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU ALA SEQRES 4 A 310 SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS ASN SEQRES 5 A 310 LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE ASP SEQRES 6 A 310 HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP TYR SEQRES 7 A 310 ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN ARG SEQRES 8 A 310 SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR CYS SEQRES 9 A 310 GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER ARG SEQRES 10 A 310 GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SER SEQRES 11 A 310 VAL LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU LYS SEQRES 12 A 310 GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR LEU SEQRES 13 A 310 ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG GLN SEQRES 14 A 310 LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG GLU SEQRES 15 A 310 ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE GLY SEQRES 16 A 310 VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU PHE SEQRES 17 A 310 LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS GLY SEQRES 18 A 310 PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SER SEQRES 19 A 310 GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU MET SEQRES 20 A 310 ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS LYS SEQRES 21 A 310 VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU ILE SEQRES 22 A 310 GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA VAL SEQRES 23 A 310 ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER VAL SEQRES 24 A 310 GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP SEQRES 1 B 310 MET ASP TYR LYS ASP ASP ASP ASP LYS LEU GLU PHE MET SEQRES 2 B 310 GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER GLY SEQRES 3 B 310 SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU ALA SEQRES 4 B 310 SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS ASN SEQRES 5 B 310 LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE ASP SEQRES 6 B 310 HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP TYR SEQRES 7 B 310 ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN ARG SEQRES 8 B 310 SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR CYS SEQRES 9 B 310 GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER ARG SEQRES 10 B 310 GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SER SEQRES 11 B 310 VAL LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU LYS SEQRES 12 B 310 GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR LEU SEQRES 13 B 310 ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG GLN SEQRES 14 B 310 LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG GLU SEQRES 15 B 310 ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE GLY SEQRES 16 B 310 VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU PHE SEQRES 17 B 310 LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS GLY SEQRES 18 B 310 PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SER SEQRES 19 B 310 GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU MET SEQRES 20 B 310 ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS LYS SEQRES 21 B 310 VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU ILE SEQRES 22 B 310 GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA VAL SEQRES 23 B 310 ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER VAL SEQRES 24 B 310 GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP HET CL A 799 1 HET 073 A 800 43 HET CL B 799 1 HET MG B 800 1 HET 073 B 801 43 HETNAM CL CHLORIDE ION HETNAM 073 (4-{(2S,4E)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-[4- HETNAM 2 073 (METHOXYCARBONYL)PHENYL]-5-PHENYLPENT-4-ENYL}PHENYL) HETNAM 3 073 (DIFLUORO)METHYLPHOSPHONIC ACID HETNAM MG MAGNESIUM ION FORMUL 3 CL 2(CL 1-) FORMUL 4 073 2(C32 H28 F2 N3 O5 P) FORMUL 6 MG MG 2+ FORMUL 8 HOH *299(H2 O) HELIX 1 1 GLU A 499 GLY A 514 1 16 HELIX 2 2 SER A 515 ALA A 527 1 13 HELIX 3 3 LEU A 537 ASN A 544 5 8 HELIX 4 4 THR A 591 GLN A 602 1 12 HELIX 5 5 SER A 687 SER A 701 1 15 HELIX 6 6 ILE A 719 ARG A 738 1 20 HELIX 7 7 ASP A 740 VAL A 744 5 5 HELIX 8 8 ASP A 745 LYS A 755 1 11 HELIX 9 9 THR A 763 MET A 782 1 20 HELIX 10 10 GLU B 499 GLY B 514 1 16 HELIX 11 11 SER B 515 ALA B 527 1 13 HELIX 12 12 LEU B 537 ASN B 544 5 8 HELIX 13 13 THR B 591 GLN B 602 1 12 HELIX 14 14 SER B 687 SER B 701 1 15 HELIX 15 15 ILE B 719 ARG B 738 1 20 HELIX 16 16 ASP B 740 VAL B 744 5 5 HELIX 17 17 ASP B 745 LYS B 755 1 11 HELIX 18 18 THR B 763 MET B 782 1 20 SHEET 1 A 9 ARG A 556 LYS A 558 0 SHEET 2 A 9 TYR A 566 MET A 574 -1 O ALA A 569 N ILE A 557 SHEET 3 A 9 ARG A 579 THR A 584 -1 O TYR A 581 N ILE A 572 SHEET 4 A 9 VAL A 711 HIS A 714 1 O VAL A 713 N ILE A 582 SHEET 5 A 9 GLY A 606 MET A 609 1 N VAL A 608 O VAL A 712 SHEET 6 A 9 THR A 668 TYR A 676 1 O PHE A 674 N VAL A 607 SHEET 7 A 9 TYR A 653 ASN A 662 -1 N LEU A 658 O ILE A 671 SHEET 8 A 9 LEU A 640 ILE A 649 -1 N ASP A 648 O VAL A 655 SHEET 9 A 9 MET A 633 PHE A 635 -1 N PHE A 635 O LEU A 640 SHEET 1 B 9 ARG B 556 LYS B 558 0 SHEET 2 B 9 TYR B 566 MET B 574 -1 O ALA B 569 N ILE B 557 SHEET 3 B 9 ARG B 579 THR B 584 -1 O TYR B 581 N ILE B 572 SHEET 4 B 9 VAL B 711 HIS B 714 1 O VAL B 713 N ILE B 582 SHEET 5 B 9 GLY B 606 MET B 609 1 N VAL B 608 O VAL B 712 SHEET 6 B 9 THR B 668 TYR B 676 1 O PHE B 674 N VAL B 607 SHEET 7 B 9 TYR B 653 ASN B 662 -1 N THR B 654 O HIS B 675 SHEET 8 B 9 LEU B 640 ILE B 649 -1 N LYS B 641 O GLU B 661 SHEET 9 B 9 MET B 633 PHE B 635 -1 N PHE B 635 O LEU B 640 LINK MG MG B 800 O HOH B 850 1555 1555 2.22 LINK MG MG B 800 O HOH B 857 1555 3545 2.37 LINK MG MG B 800 O HOH B 873 1555 3545 1.95 LINK MG MG B 800 O HOH B 914 1555 3545 2.17 LINK MG MG B 800 O HOH B 945 1555 3545 2.51 SITE 1 AC1 4 ARG B 524 ARG B 754 GLN B 762 073 B 801 SITE 1 AC2 4 ARG A 524 ARG A 754 GLN A 762 ARG B 524 SITE 1 AC3 6 HIS B 554 HOH B 850 HOH B 857 HOH B 873 SITE 2 AC3 6 HOH B 914 HOH B 945 SITE 1 AC4 19 TYR A 546 ARG A 547 ASP A 548 VAL A 549 SITE 2 AC4 19 ASP A 681 PHE A 682 CYS A 715 SER A 716 SITE 3 AC4 19 ALA A 717 GLY A 718 ILE A 719 GLY A 720 SITE 4 AC4 19 ARG A 721 MET A 758 GLN A 762 HOH A 802 SITE 5 AC4 19 ALA B 518 ASP B 522 HIS B 525 SITE 1 AC5 21 ALA A 518 ASP A 522 HIS A 525 GLU A 526 SITE 2 AC5 21 TYR B 546 ARG B 547 ASP B 548 VAL B 549 SITE 3 AC5 21 ASP B 681 PHE B 682 CYS B 715 SER B 716 SITE 4 AC5 21 ALA B 717 GLY B 718 ILE B 719 GLY B 720 SITE 5 AC5 21 ARG B 721 MET B 758 GLN B 762 CL B 799 SITE 6 AC5 21 HOH B 804 CRYST1 86.431 86.621 139.193 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011570 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011545 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007184 0.00000